Literature DB >> 32205068

Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Zareen M Farukhi1, Olga V Demler1, Michael P Caulfield2, Krishnaji Kulkarni3, Jay Wohlgemuth2, Michael Cobble3, Heike Luttmann-Gibson4, Chunying Li5, John R Nelson6, Nancy R Cook5, Julie E Buring5, Ronald M Krauss7, JoAnn E Manson5, Samia Mora8.   

Abstract

BACKGROUND: Elevated postprandial triglycerides reflect a proatherogenic milieu, but underlying mechanisms are unclear.
OBJECTIVE: We examined differences between fasting and nonfasting profiles of directly measured lipoprotein size and subfractions to assess if postprandial triglycerides reflected increases in very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL) and remnants, or small dense lipid depleted LDL (sdLDL) particles.
METHODS: We conducted a cross-sectional analysis of 15,397 participants (10,135 fasting; 5262 nonfasting [<8 hours since last meal]) from the VITamin D and OmegA-3 TriaL. Baseline cholesterol subfractions were measured by the vertical auto profile method and particle subfractions by ion mobility. We performed multivariable linear regression adjusting for cardiovascular and lipoprotein-modifying risk factors.
RESULTS: Mean age (SD) was 68.0 years (±7.0), with 50.9% women. Adjusted mean triglyceride concentrations were higher nonfasting by 17.8 ± 1.3%, with higher nonfasting levels of directly measured VLDL cholesterol (by 3.5 ± 0.6%) and total VLDL particles (by 2.0 ± 0.7%), specifically large VLDL (by 12.3 ± 1.3%) and medium VLDL particles (by 5.3 ± 0.8%), all P < .001. By contrast, lower concentrations of low density lipoprotein (LDL) and IDL cholesterol and particles were noted for nonfasting participants. sdLDL cholesterol levels and particle concentrations showed no statistically significant difference by fasting status (-1.3 ± 2.1% and 0.07 ± 0.6%, respectively, P > .05).
CONCLUSIONS: Directly measured particle and cholesterol concentrations of VLDL, not sdLDL, were higher nonfasting and may partly contribute to the proatherogenicity of postprandial hypertriglyceridemia. These differences, although statistically significant, were small and may not fully explain the increased risk of postprandial hypertriglyceridemia.
Copyright © 2020 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lipoprotein subfractions; Nonfasting lipids; Postprandial state; Triglyceride-rich lipoproteins

Mesh:

Substances:

Year:  2020        PMID: 32205068      PMCID: PMC7166180          DOI: 10.1016/j.jacl.2020.02.005

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  25 in total

Review 1.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 2.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

3.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

4.  The characteristics of remnant lipoproteins in the fasting and postprandial plasma.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Shin-ichi Yatsuzuka; Younosuke Shimomura; Akira Tanaka; Hiroyuki Sumino; Makoto Nara; Tetsuo Machida; Masami Murakami
Journal:  Clin Chim Acta       Date:  2012-03-13       Impact factor: 3.786

5.  Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.

Authors:  Katsuyuki Nakajima; Yoshiharu Tokita; Koji Sakamaki; Younosuke Shimomura; Junji Kobayashi; Keiko Kamachi; Akira Tanaka; Kimber L Stanhope; Peter J Havel; Tao Wang; Tetsuo Machida; Masami Murakami
Journal:  Clin Chim Acta       Date:  2016-12-14       Impact factor: 3.786

6.  Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.

Authors:  F Karpe; M L Hellénius; A Hamsten
Journal:  Metabolism       Date:  1999-03       Impact factor: 8.694

7.  Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.

Authors:  M Shaikh; R Wootton; B G Nordestgaard; P Baskerville; J S Lumley; A E La Ville; J Quiney; B Lewis
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

8.  Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes.

Authors:  M Ai; A Tanaka; K Ogita; M Sekinc; F Numano; F Numano; G M Reaven
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

9.  Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).

Authors:  Shari S Bassuk; JoAnn E Manson; I-Min Lee; Nancy R Cook; William G Christen; Vadim Y Bubes; David S Gordon; Trisha Copeland; Georgina Friedenberg; Denise M D'Agostino; Claire Y Ridge; Jean G MacFadyen; Kate Kalan; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2016-01-06       Impact factor: 2.226

Review 10.  Postprandial Hyperlipidemia and Remnant Lipoproteins.

Authors:  Daisaku Masuda; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2016-11-08       Impact factor: 4.928

View more
  6 in total

1.  Nonfasting Lipids for All Patients?

Authors:  Zareen Farukhi; Samia Mora
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

Review 2.  Assessing the dyslipidemias: to fast or not to fast?

Authors:  Zareen Farukhi; Samia Mora
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-04-01       Impact factor: 3.243

3.  Small Dense Low-Density Lipoprotein Cholesterol is a Potential Marker for Predicting Laser Treatment for Retinopathy in Diabetic Patients.

Authors:  Atsuko Nakayama; Hiroyuki Morita; Tatsuyuki Sato; Takuya Kawahara; Norifumi Takeda; Satoshi Kato; Hiroshi Itoh; Issei Komuro
Journal:  J Atheroscler Thromb       Date:  2021-05-14       Impact factor: 4.394

4.  Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice.

Authors:  Xiaoyu Hou; An Song; Yunpeng Guan; Peipei Tian; Luping Ren; Yong Tang; Chao Wang; Ling Gao; Guangyao Song; Xiaoping Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-18       Impact factor: 5.555

5.  The accuracy of four formulas for LDL-C calculation at the fasting and postprandial states.

Authors:  Jin Xu; Xiao Du; Shilan Zhang; Qunyan Xiang; Liyuan Zhu; Ling Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-18

Review 6.  Low-density lipoprotein particles in atherosclerosis.

Authors:  Ya-Nan Qiao; Yan-Li Zou; Shou-Dong Guo
Journal:  Front Physiol       Date:  2022-08-30       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.